Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Brothers Life Sciences Lp
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   28,278,373    

Indirect Shares

   99,473,529      
Direct Value   $941,991,056    

Indirect Value

   $2,801,738,789      
Total Shares   127,751,902      
Total Value   $3,743,729,845      


Synageva BioPharma Corp $0 XOMA Corporation $327,634,719 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,143,891 Incyte Corp $7,037,243 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,047,349 Kiniksa Pharmaceuticals, Ltd. $584,993 Synageva BioPharma Corp $0 XOMA Corporation $327,634,719 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,143,891 Incyte Corp $7,037,243 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,047,349 Kiniksa Pharmaceuticals, Ltd. $584,993
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    1    

     Stock price went up :
    11   
    0    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   5.5   
   -1.0   
     Percentage Gain/Loss :
   19.7%
 -23.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Director 2012-07-13 5,077,676 0    Premium*  
            XOMA Corporation XOMA Director 2012-07-19 13,606,093 0    Premium*  
            Genomic Health Inc GHDX Director 2012-07-26 9,086,690 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2023-06-01 205,752 2023-06-01 39,330,977    Premium*  
            Seagen Inc SGEN Former 10% Owner, Dire... 2023-12-14 0 2023-12-14 0    Premium*  
            Incyte Corp INCY Director, 10% Owner 2017-09-08 119,681 2017-09-08 822,826    Premium*  
            Aceragen, Inc ACGN Director 0 2014-03-10 1,613,076    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2017-06-15 131,963 2017-06-15 1,074,556    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2023-11-14 20,838 2023-11-14 9,878,124    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 2021-11-18 0 2021-11-18 7,625,425    Premium*  
            Tscan Therapeutics, Inc. TCRX Director, 10% Owner 2022-05-10 0 2022-05-11 2,528,583    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 2022-06-13 0 2022-06-13 29,190,248    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director 2023-06-06 29,680 2023-06-06 2,719,343    Premium*  
            Igm Biosciences, Inc. IGMS Director 2023-06-30 0 2023-09-29 2,896,968    Premium*  
            Madrigal Pharmaceuticals Inc MDGL Director 2023-11-14 0 2023-12-14 1,793,403    Premium*  
* Premium Members only  

Records found :    114         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2016-03-17 4 B $31.73 $3,951,304 I/I 124,065 38,783,387 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-14 4 B $33.77 $4,016,519 I/I 118,941 37,562,036 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-25 4 B $29.86 $4,261,553 I/I 142,702 35,718,720 2.25 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-12-14 4 B $226.97 $4,710,893 I/I 20,633 1,793,403 2.1 %
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2023-05-23 4 B $25.33 $5,312,458 I/I 209,053 38,811,515 2.25 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-14 4 B $156.42 $5,347,837 I/I 34,188 1,531,757 2.1 %
SGEN Seagen Inc Director   –       •       •   2016-02-12 4 B $27.28 $5,410,745 I/I 193,717 3,933,240 2.25 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-14 4 B $152.21 $5,799,653 I/I 37,660 1,500,227 2.1 %
SGEN Seagen Inc Director   –       •       •   2015-11-19 4 B $43.93 $5,845,378 I/I 133,073 33,247,205 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-11 4 B $32.34 $6,480,738 I/I 195,765 37,454,776 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-06 4 B $44.98 $6,580,527 I/I 143,363 4,643,343 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-09 4 B $31.15 $6,683,985 I/I 208,670 37,017,863 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-13 4 B $50.00 $7,213,981 I/I 141,202 39,432,496 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-02-24 4 B $33.60 $7,341,491 I/I 217,465 24,210,609 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-22 4 B $30.21 $7,354,639 I/I 243,411 35,475,868 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-18 4 B $29.94 $7,530,349 I/I 251,534 34,800,251 2.25 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-12-12 4 B $205.32 $7,548,616 I/I 34,578 1,699,129 2.1 %
SGEN Seagen Inc Director   –       •       •   2016-02-29 4 B $30.34 $7,650,310 I/I 251,722 35,985,436 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-11-20 4 B $43.87 $7,988,259 I/I 181,647 33,428,852 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-16 4 B $29.19 $8,049,663 I/I 270,163 33,847,095 2.25 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-17 4 B $167.63 $8,100,704 I/I 46,370 1,588,541 2.1 %
SGEN Seagen Inc Director   –       •       •   2015-05-19 4 B $40.57 $8,751,248 I/I 214,129 26,268,629 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-04 4 B $31.68 $9,322,814 I/I 288,058 36,627,462 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-10 4 B $32.30 $9,386,567 I/I 290,231 37,278,782 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-03-09 4 B $34.62 $9,556,609 I/I 275,717 24,998,817 2.25 -
  114  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us